INmune Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 948.36 K | $7.41 M | -4.16% | 4.22% |
PRAETORIAN PR LLC | 05/15/2025 | 865.00 K | $6.76 M | 6.50% | 3.85% |
VANGUARD GROUP INC | 05/09/2025 | 826.61 K | $6.46 M | 11.98% | 3.67% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 382.04 K | $2.98 M | -19.66% | 1.70% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 364.86 K | $2.85 M | 0.35% | 1.62% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 241.25 K | $1.88 M | -17.19% | 1.07% |
STATE STREET CORP | 05/15/2025 | 236.13 K | $1.84 M | 4.28% | 1.05% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2025 | 178.28 K | $1.39 M | 0.00% | 0.79% |
NORTHERN TRUST CORP | 05/13/2025 | 152.45 K | $1.19 M | 43.87% | 0.68% |
05/07/2025 | 130.68 K | $1.02 M | -31.87% | 0.58% | |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 109.30 K | $853.63 K | -21.82% | 0.49% |
MAI CAPITAL MANAGEMENT | 05/15/2025 | 106.80 K | $834.09 K | 5.98% | 0.47% |
CITADEL ADVISORS LLC | 05/15/2025 | 101.51 K | $792.80 K | 94.48% | 0.45% |
PEKIN HARDY STRAUSS, INC. | 04/30/2025 | 94.30 K | $736.48 K | 13.14% | 0.42% |
WESTSIDE INVESTMENT MANAGEMENT, INC. | 04/25/2025 | 89.20 K | $696.66 K | -0.86% | 0.40% |
MORGAN STANLEY | 05/15/2025 | 84.46 K | $659.66 K | -45.55% | 0.38% |
05/07/2025 | 68.00 K | $531.08 K | 100.00% | 0.30% | |
MARSHALL WACE, LLP | 05/15/2025 | 58.09 K | $453.66 K | -25.02% | 0.26% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 56.80 K | $443.61 K | 126.29% | 0.25% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 54.92 K | $428.95 K | 8.97% | 0.24% |
WARATAH CAPITAL ADVISORS LTD. | 05/13/2025 | 53.77 K | $419.98 K | 100.00% | 0.24% |
FERMATA ADVISORS, LLC | 04/10/2025 | 50.00 K | $390.48 K | 6.38% | 0.22% |
SIMPLEX TRADING, LLC | 05/12/2025 | 42.81 K | $334.00 K | 100.00% | 0.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 41.32 K | $322.71 K | 19.19% | 0.18% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 40.72 K | $317.99 K | -36.00% | 0.18% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 40.30 K | $314.70 K | 71.50% | 0.18% |
NATIONAL BANK OF CANADA /FI/ | 05/12/2025 | 39.50 K | $308.49 K | 19,650.00% | 0.18% |
DEUTSCHE BANK AG\ | 05/09/2025 | 38.01 K | $296.87 K | -65.40% | 0.17% |
XTX TOPCO LTD | 05/08/2025 | 36.92 K | $288.34 K | -39.74% | 0.16% |
LAIRD NORTON TRUST COMPANY, LLC | 05/15/2025 | 36.60 K | $285.85 K | 7.33% | 0.16% |
CITADEL ADVISORS LLC | 05/15/2025 | 34.80 K | $271.79 K | 95.51% | 0.15% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 30.56 K | $238.70 K | -53.96% | 0.14% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 30.39 K | $237.37 K | -0.18% | 0.14% |
ROYAL BANK OF CANADA | 05/15/2025 | 29.86 K | $233.00 K | 44.78% | 0.13% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 25.14 K | $196.34 K | 0.00% | 0.11% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/22/2025 | 23.08 K | $180.00 K | 100.00% | 0.10% |
COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 19.89 K | $155.00 K | 100.00% | 0.09% |
BARCLAYS PLC | 05/15/2025 | 19.84 K | $154.00 K | -38.03% | 0.09% |
WOLVERINE TRADING, LLC | 05/15/2025 | 19.39 K | $145.83 K | 100.00% | 0.09% |
HSBC HOLDINGS PLC | 05/14/2025 | 19.39 K | $144.81 K | -23.11% | 0.09% |
RHUMBLINE ADVISERS | 04/08/2025 | 19.15 K | $149.58 K | 14.39% | 0.09% |
05/15/2025 | 17.24 K | $134.65 M | 100.00% | 0.08% | |
DIAMETRIC CAPITAL, LP | 05/14/2025 | 16.54 K | $129.14 K | -54.94% | 0.07% |
05/12/2025 | 16.52 K | $129.01 K | 100.00% | 0.07% | |
GROUP ONE TRADING, L.P. | 05/14/2025 | 15.53 K | $121.26 K | 100.00% | 0.07% |
FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 04/28/2025 | 15.50 K | $121.06 K | 0.00% | 0.07% |
CITADEL ADVISORS LLC | 05/15/2025 | 14.80 K | $115.59 K | -76.32% | 0.07% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 13.93 K | $108.75 K | 505.43% | 0.06% |
WOLVERINE TRADING, LLC | 05/15/2025 | 12.40 K | $93.25 K | 100.00% | 0.06% |
QUADRATURE CAPITAL LTD | 05/13/2025 | 12.30 K | $95.83 K | 100.00% | 0.05% |
INmune Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 90 institutional investors and hedge funds held shares of INmune Bio, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 948,362
Praetorian PR LLC: 865,000
VANGUARD GROUP INC: 826,613
RAYMOND JAMES FINANCIAL INC: 382,041
GEODE CAPITAL MANAGEMENT, LLC: 364,862
MILLENNIUM MANAGEMENT LLC: 241,248
26.35% of INmune Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.56 M shares in the last 24 months. This purchase volume represents approximately $55.57 M in transactions.